SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-085846
Filing Date
2023-11-13
Accepted
2023-11-13 13:04:37
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_bioessence.htm   iXBRL 10-Q 624511
2 CERTIFICATION f10q0923ex31-1_bioessence.htm EX-31.1 11025
3 CERTIFICATION f10q0923ex31-2_bioessence.htm EX-31.2 10815
4 CERTIFICATION f10q0923ex32-1_bioessence.htm EX-32.1 5525
5 CERTIFICATION f10q0923ex32-2_bioessence.htm EX-32.2 6185
6 GRAPHIC image_001.jpg GRAPHIC 7168
  Complete submission text file 0001213900-23-085846.txt   4392189

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bioe-20230930.xsd EX-101.SCH 49682
8 XBRL CALCULATION FILE bioe-20230930_cal.xml EX-101.CAL 58046
9 XBRL DEFINITION FILE bioe-20230930_def.xml EX-101.DEF 218756
10 XBRL LABEL FILE bioe-20230930_lab.xml EX-101.LAB 442371
11 XBRL PRESENTATION FILE bioe-20230930_pre.xml EX-101.PRE 231923
68 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_bioessence_htm.xml XML 454744
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 231397213
SIC: 2834 Pharmaceutical Preparations